These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 19679549)

  • 1. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.
    Kisfalvi K; Eibl G; Sinnett-Smith J; Rozengurt E
    Cancer Res; 2009 Aug; 69(16):6539-45. PubMed ID: 19679549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
    Rozengurt E; Sinnett-Smith J; Kisfalvi K
    Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
    Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
    PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
    Soares HP; Ni Y; Kisfalvi K; Sinnett-Smith J; Rozengurt E
    PLoS One; 2013; 8(2):e57289. PubMed ID: 23437362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between insulin receptor and G protein-coupled receptor signaling systems leads to Ca²+ oscillations in pancreatic cancer PANC-1 cells.
    Young SH; Rozengurt E
    Biochem Biophys Res Commun; 2010 Oct; 401(1):154-8. PubMed ID: 20849815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.
    Hao F; Xu Q; Zhao Y; Stevens JV; Young SH; Sinnett-Smith J; Rozengurt E
    Mol Cancer Res; 2017 Jul; 15(7):929-941. PubMed ID: 28360038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin potentiates Ca2+ signaling and phosphatidylinositol 4,5-bisphosphate hydrolysis induced by Gq protein-coupled receptor agonists through an mTOR-dependent pathway.
    Kisfalvi K; Rey O; Young SH; Sinnett-Smith J; Rozengurt E
    Endocrinology; 2007 Jul; 148(7):3246-57. PubMed ID: 17379645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK.
    Sinnett-Smith J; Kisfalvi K; Kui R; Rozengurt E
    Biochem Biophys Res Commun; 2013 Jan; 430(1):352-7. PubMed ID: 23159620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
    Karnevi E; Said K; Andersson R; Rosendahl AH
    BMC Cancer; 2013 May; 13():235. PubMed ID: 23663483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
    Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E
    Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits the growth of human pancreatic cancer xenografts.
    Kisfalvi K; Moro A; Sinnett-Smith J; Eibl G; Rozengurt E
    Pancreas; 2013 Jul; 42(5):781-5. PubMed ID: 23462329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
    Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
    Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
    Zhou G; Yu J; Wang A; Liu SH; Sinnett-Smith J; Wu J; Sanchez R; Nemunaitis J; Ricordi C; Rozengurt E; Brunicardi FC
    Curr Mol Med; 2016; 16(1):83-90. PubMed ID: 26695692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway.
    Zhu M; Zhang Q; Wang X; Kang L; Yang Y; Liu Y; Yang L; Li J; Yang L; Liu J; Li Y; Zu L; Shen Y; Qi Z
    Oncotarget; 2016 Dec; 7(51):84190-84200. PubMed ID: 27705937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts.
    Lipner MB; Marayati R; Deng Y; Wang X; Raftery L; O'Neil BH; Yeh JJ
    PLoS One; 2016; 11(1):e0147113. PubMed ID: 26760500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin induces apoptosis of pancreatic cancer cells.
    Wang LW; Li ZS; Zou DW; Jin ZD; Gao J; Xu GM
    World J Gastroenterol; 2008 Dec; 14(47):7192-8. PubMed ID: 19084933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
    Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
    Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.
    Harikumar KB; Kunnumakkara AB; Ochi N; Tong Z; Deorukhkar A; Sung B; Kelland L; Jamieson S; Sutherland R; Raynham T; Charles M; Bagherzadeh A; Foxton C; Boakes A; Farooq M; Maru D; Diagaradjane P; Matsuo Y; Sinnett-Smith J; Gelovani J; Krishnan S; Aggarwal BB; Rozengurt E; Ireson CR; Guha S
    Mol Cancer Ther; 2010 May; 9(5):1136-46. PubMed ID: 20442301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin reduces pancreatic cancer cell proliferation and increases apoptosis through MTOR signaling pathway and its dose-effect relationship.
    Zhao HW; Zhou N; Jin F; Wang R; Zhao JQ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5336-5344. PubMed ID: 32495867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.